# K-RAS and EGFR in Lung Cancer

> **NCT03951233** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 424 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03951233
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03951233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03951233, "K-RAS and EGFR in Lung Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03951233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*